BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21258967)

  • 1. Interleukin-2 -330T>G genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Yoshino K; Nakatsu T; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2011 Jul; 18(7):1995-2002. PubMed ID: 21258967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
    Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
    J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 -634G>C genetic polymorphism is associated with prognosis following surgery for advanced thoracic esophageal squamous cell carcinoma.
    Motoyama S; Nakatsu T; Miura M; Hinai Y; Minamiya Y; Ogawa J
    Dig Surg; 2012; 29(3):194-201. PubMed ID: 22677780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
    Lee JM; Yang SY; Yang PW; Shun CT; Wu MT; Hsu CH; Lin CC; Cheng JC; Wang YH; Chuang TH; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Ann Surg Oncol; 2011 Jul; 18(7):2066-73. PubMed ID: 21298351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer.
    Mahmoodi M; Mir MR; Daryaei P; Harirchi I; Rezaei N; Mohagheghi MA; Mousavi-Jarrahi A; Nahavandian B; Kavianpour M; Jafari A
    Eur Cytokine Netw; 2008 Jun; 19(2):92-8. PubMed ID: 18632423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance].
    Wei YC; Hu FB; Shen Y; Xu LH; Lin LS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1271-3. PubMed ID: 15567776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
    Zhang DK; Su XD; Lin P
    Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
    J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
    Yuequan J; Shifeng C; Bing Z
    Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
    Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
    Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.